Cabotegravir Sodium
Modify Date: 2024-01-02 11:47:40
Cabotegravir Sodium structure
|
Common Name | Cabotegravir Sodium | ||
|---|---|---|---|---|
| CAS Number | 1051375-13-3 | Molecular Weight | 427.334 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H16F2N3NaO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cabotegravir SodiumCabotegravir sodium is a highly potent HIV integrase inhibitor with an IC50 value of 2.5 nM for HIVADA. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral drugs (ARVs)[1]. |
| Name | CABOTEGRAVIR SODIUM |
|---|---|
| Synonym | More Synonyms |
| Description | Cabotegravir sodium is a highly potent HIV integrase inhibitor with an IC50 value of 2.5 nM for HIVADA. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral drugs (ARVs)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.5 nM (HIVADA)[1] |
| References |
| Molecular Formula | C19H16F2N3NaO5 |
|---|---|
| Molecular Weight | 427.334 |
| Exact Mass | 427.095581 |
| S-265744B |
| Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt, (3S,11aR)- (1:1) |
| 3L12PT535M |
| CABOTEGRAVIR SODIUM |
| Sodium (3S,11aR)-8-[(2,4-difluorobenzyl)carbamoyl]-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate |
| GSK1265744B |